Rating History for 4D Molecular Therapeutics (FDMT) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/7/2025 | Judah Frommer | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
10.51 (8.48) |
-19.31% | Details |
 |
|||||||
